WHO Study: 12 Per Cent of Global Cancers Originate from Viruses and Bacteria
Cancer does not always originate from genetic factors, smoking, diet, or environmental exposure. A recent study has found that approximately 2.3 million new cancer cases worldwide in 2024 are related to viral, bacterial, and parasitic infections, accounting for about 12 per cent, or nearly one in every eight new cancer cases.
These findings originate from the International Agency for Research on Cancer (IARC), a body of the World Health Organisation (WHO), and were published in the journal The Lancet Oncology. The research utilised 2024 cancer case estimates from the IARC Global Cancer Observatory and represents one of the latest global mappings of cancers attributable to infection.
The study identified five infectious agents that contribute to almost all infection-related cancers worldwide. These are the bacterium Helicobacter pylori, human papillomavirus (HPV), hepatitis B virus (HBV), Epstein-Barr virus (EBV), and hepatitis C virus (HCV).
These findings simultaneously reveal a significant opportunity for cancer prevention. Many infection-causing cancers can already be prevented through vaccination, screening, early diagnosis, and the treatment of infections before they develop into more serious diseases.
“These findings underscore the key role that infection control can play in reducing the global cancer burden,” said Harriet Rumgay, a scientist at the IARC Cancer Surveillance Branch and one of the study’s authors, as reported by Euronews.
According to Rumgay, the world has made progress in vaccination and screening. However, cancer related to infection remains a major global health challenge, particularly because the burden is not distributed equally.
More than three-quarters of infection-related cancers are found in low- and middle-income countries. Disparities in access to vaccination, testing, diagnosis, and treatment mean that populations in these nations bear a much heavier burden.
Stomach Bacteria Identified as Largest Cause
A significant finding involves Helicobacter pylori. This bacterium, which lives in the stomach and is known as a primary cause of stomach ulcers, is the largest infectious agent contributing to cancer globally.
IARC estimates that H. pylori is linked to approximately 760,000 new cancer cases in 2024, most of which are gastric cancers. This figure is slightly higher than cancers associated with HPV, which contributed approximately 750,000 new cases throughout 2024.
While HPV is most widely known as the primary cause of cervical cancer, its impact extends further. The infection can also cause anal, vulvar, vaginal, and penile cancers, as well as several head and neck cancers. Cervical cancer serves as one of the clearest examples of the link between infection and cancer; IARC notes that almost all cervical cancers are linked to HPV infection, making vaccination and screening two primary weapons in reducing cases.
Following this is hepatitis B. The HBV virus is linked to approximately 360,000 cancer cases in 2024, most of which are liver cancers. Next is the Epstein-Barr virus with approximately 260,000 cases. This very common human virus is linked to nasopharyngeal cancer, several types of lymphoma, and some gastric cancers. Hepatitis C follows with approximately 160,000 cases, the majority of which are also liver cancers. These five agents account for almost all the world’s infection-related cancers.
Epstein-Barr Virus Becomes New Focus
One of the key findings of the recent research concerns the Epstein-Barr virus (EBV). While this virus has long been known to be linked to several types of cancer, new scientific evidence has expanded the list of cancers it can be associated with.
IARC’s analysis includes new evidence that EBV also contributes to some gastric cancers. With this development, EBV is now the fourth largest cause of infection-related cancer globally, surpassing hepatitis C.
The challenge is that, to date, no EBV vaccine has been approved for widespread use. This differs from HPV and hepatitis B, which already have effective vaccines.
“This recent analysis shows that the landscape of infection-related cancer continues to evolve as scientific evidence advances,” said Gary Clifford, one of the study’s senior authors.
According to Clifford, investing in new prevention tools could yield a massive impact, particularly for infections like EBV, which currently lacks an effective vaccine. Researchers also highlighted the need to develop vaccines and prevention strategies for H. pylori and Kaposi sarcoma-associated herpesvirus (KSHV), which currently lack prevention methods as robust as those for HPV and hepatitis B.
Source: jawawa.id (https://jawawa.id/newsitem/who-study-12-per-cent-of-global-cancers-originate-from-viruses-and-bacteria-1790841344)
Originally published by Republika (https://ameera.republika.co.id/berita/tm7ukj451/studi-who-12-persen-kanker-dunia-berawal-dari-virus-dan-bakteri), translated from Indonesian